These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6680219)

  • 1. Dose-incidence curves for tumour control and normal tissue injury, in relation to the response of clonogenic cells.
    Moore JV; Hendry JH; Hunter RD
    Radiother Oncol; 1983 Nov; 1(2):143-57. PubMed ID: 6680219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour and normal tissue responses to fractionated non-uniform dose delivery.
    Källman P; Agren A; Brahme A
    Int J Radiat Biol; 1992 Aug; 62(2):249-62. PubMed ID: 1355519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of dose-response relationships for late radiation effects: an analysis of skin telangiectasia and of head and neck morbidity.
    Turesson I
    Radiother Oncol; 1991 Mar; 20(3):149-58. PubMed ID: 1852906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response curve and split-dose recovery in human skin cancer.
    Trott KR; Maciejewski B; Preuss-Bayer G; Skolyszewski J
    Radiother Oncol; 1984 Aug; 2(2):123-9. PubMed ID: 6505282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent dose-response relation for absence of vaginal elasticity after gynecological radiation therapy.
    Alevronta E; Åvall-Lundqvist E; Al-Abany M; Nyberg T; Lind H; Waldenström AC; Olsson C; Dunberger G; Bergmark K; Steineck G; Lind BK
    Radiother Oncol; 2016 Sep; 120(3):537-541. PubMed ID: 26907514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivation of the expressions for gamma50 and D50 for different individual TCP and NTCP models.
    Stavreva N; Stavrev P; Warkentin B; Fallone BG
    Phys Med Biol; 2002 Oct; 47(20):3591-604. PubMed ID: 12433122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high steepness of dose-response curves for late-responding normal tissues.
    Thames HD; Hendry JH; Moore JV; Ang KK; Travis EL
    Radiother Oncol; 1989 May; 15(1):49-53. PubMed ID: 2748942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical appraisal of clonogenic survival assays in the evaluation of radiation damage to normal tissues.
    Michalowski A
    Radiother Oncol; 1984 Jan; 1(3):241-6. PubMed ID: 6505260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can cell survival parameters be deduced from non clonogenic assays of radiation damage to normal tissues?
    Michalowski A; Wheldon TE; Kirk J
    Br J Cancer Suppl; 1984; 6():257-61. PubMed ID: 6582914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dose response of human tumors and normal tissues during and after fractionated radiation treatment. A new model.
    van de Geijn J
    Radiother Oncol; 1988 May; 12(1):57-78. PubMed ID: 3406453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-Response Modeling of the Visual Pathway Tolerance to Single-Fraction and Hypofractionated Stereotactic Radiosurgery.
    Hiniker SM; Modlin LA; Choi CY; Atalar B; Seiger K; Binkley MS; Harris JP; Liao YJ; Fischbein N; Wang L; Ho A; Lo A; Chang SD; Harsh GR; Gibbs IC; Hancock SL; Li G; Adler JR; Soltys SG
    Semin Radiat Oncol; 2016 Apr; 26(2):97-104. PubMed ID: 27000505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to continuous irradiation (CI) in relation to the initial slope of the cell survival curve for tumours and bone marrow.
    Stephens TC; Peacock JH; Shipley WU; Steel GG
    Br J Cancer Suppl; 1984; 6():271-4. PubMed ID: 6582916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying the position and steepness of radiation dose-response curves.
    Bentzen SM; Tucker SL
    Int J Radiat Biol; 1997 May; 71(5):531-42. PubMed ID: 9191898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation of the optimum dose per fraction from the linear quadratic model.
    Jones B; Tan LT; Dale RG
    Br J Radiol; 1995 Aug; 68(812):894-902. PubMed ID: 7551788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flexure dose: the low-dose limit of effective fractionation.
    Tucker SL; Thames HD
    Int J Radiat Oncol Biol Phys; 1983 Sep; 9(9):1373-83. PubMed ID: 6885550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cellular interpretation of tumour radioresistance.
    Trott KR
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():81-3. PubMed ID: 6733720
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiation response of hypoxic and generally heterogeneous tissues.
    Nilsson J; Lind BK; Brahme A
    Int J Radiat Biol; 2002 May; 78(5):389-405. PubMed ID: 12020429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
    Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
    Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor radioresponsiveness versus fractionation sensitivity.
    Thames HD; Suit HD
    Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):687-91. PubMed ID: 3700173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An approach to the interpretation of clinical data on the tumour control probability-dose relationship.
    Dutreix J; Tubiana M; Dutreix A
    Radiother Oncol; 1988 Mar; 11(3):239-48. PubMed ID: 3283850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.